Request for Covid-19 Impact Assessment of this Report
The United States Peptides market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peptides market, reaching US$ million by the year 2028. As for the Europe Peptides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peptides players cover Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, and Troikaa Pharmaceuticals Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Insulin
Teriparatide
Liraglutide
Leuprolide
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Diabetes
Infectious Diseases
Cancer
Osteoporosis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peptides Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Peptides by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Peptides by Country/Region, 2017, 2022 & 2028
2.2 Peptides Segment by Type
2.2.1 Insulin
2.2.2 Teriparatide
2.2.3 Liraglutide
2.2.4 Leuprolide
2.3 Peptides Sales by Type
2.3.1 Global Peptides Sales Market Share by Type (2017-2022)
2.3.2 Global Peptides Revenue and Market Share by Type (2017-2022)
2.3.3 Global Peptides Sale Price by Type (2017-2022)
2.4 Peptides Segment by Application
2.4.1 Diabetes
2.4.2 Infectious Diseases
2.4.3 Cancer
2.4.4 Osteoporosis
2.5 Peptides Sales by Application
2.5.1 Global Peptides Sale Market Share by Application (2017-2022)
2.5.2 Global Peptides Revenue and Market Share by Application (2017-2022)
2.5.3 Global Peptides Sale Price by Application (2017-2022)
3 Global Peptides by Company
3.1 Global Peptides Breakdown Data by Company
3.1.1 Global Peptides Annual Sales by Company (2020-2022)
3.1.2 Global Peptides Sales Market Share by Company (2020-2022)
3.2 Global Peptides Annual Revenue by Company (2020-2022)
3.2.1 Global Peptides Revenue by Company (2020-2022)
3.2.2 Global Peptides Revenue Market Share by Company (2020-2022)
3.3 Global Peptides Sale Price by Company
3.4 Key Manufacturers Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peptides Product Location Distribution
3.4.2 Players Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Peptides by Geographic Region
4.1 World Historic Peptides Market Size by Geographic Region (2017-2022)
4.1.1 Global Peptides Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Peptides Annual Revenue by Geographic Region
4.2 World Historic Peptides Market Size by Country/Region (2017-2022)
4.2.1 Global Peptides Annual Sales by Country/Region (2017-2022)
4.2.2 Global Peptides Annual Revenue by Country/Region
4.3 Americas Peptides Sales Growth
4.4 APAC Peptides Sales Growth
4.5 Europe Peptides Sales Growth
4.6 Middle East & Africa Peptides Sales Growth
5 Americas
5.1 Americas Peptides Sales by Country
5.1.1 Americas Peptides Sales by Country (2017-2022)
5.1.2 Americas Peptides Revenue by Country (2017-2022)
5.2 Americas Peptides Sales by Type
5.3 Americas Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptides Sales by Region
6.1.1 APAC Peptides Sales by Region (2017-2022)
6.1.2 APAC Peptides Revenue by Region (2017-2022)
6.2 APAC Peptides Sales by Type
6.3 APAC Peptides Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Peptides by Country
7.1.1 Europe Peptides Sales by Country (2017-2022)
7.1.2 Europe Peptides Revenue by Country (2017-2022)
7.2 Europe Peptides Sales by Type
7.3 Europe Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptides by Country
8.1.1 Middle East & Africa Peptides Sales by Country (2017-2022)
8.1.2 Middle East & Africa Peptides Revenue by Country (2017-2022)
8.2 Middle East & Africa Peptides Sales by Type
8.3 Middle East & Africa Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peptides
10.3 Manufacturing Process Analysis of Peptides
10.4 Industry Chain Structure of Peptides
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peptides Distributors
11.3 Peptides Customer
12 World Forecast Review for Peptides by Geographic Region
12.1 Global Peptides Market Size Forecast by Region
12.1.1 Global Peptides Forecast by Region (2023-2028)
12.1.2 Global Peptides Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peptides Forecast by Type
12.7 Global Peptides Forecast by Application
13 Key Players Analysis
13.1 Cipla Ltd.
13.1.1 Cipla Ltd. Company Information
13.1.2 Cipla Ltd. Peptides Product Offered
13.1.3 Cipla Ltd. Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Cipla Ltd. Main Business Overview
13.1.5 Cipla Ltd. Latest Developments
13.2 Emcure Pharmaceuticals Pvt. Ltd.
13.2.1 Emcure Pharmaceuticals Pvt. Ltd. Company Information
13.2.2 Emcure Pharmaceuticals Pvt. Ltd. Peptides Product Offered
13.2.3 Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Emcure Pharmaceuticals Pvt. Ltd. Main Business Overview
13.2.5 Emcure Pharmaceuticals Pvt. Ltd. Latest Developments
13.3 Gland Pharma Limited
13.3.1 Gland Pharma Limited Company Information
13.3.2 Gland Pharma Limited Peptides Product Offered
13.3.3 Gland Pharma Limited Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Gland Pharma Limited Main Business Overview
13.3.5 Gland Pharma Limited Latest Developments
13.4 Troikaa Pharmaceuticals Ltd.
13.4.1 Troikaa Pharmaceuticals Ltd. Company Information
13.4.2 Troikaa Pharmaceuticals Ltd. Peptides Product Offered
13.4.3 Troikaa Pharmaceuticals Ltd. Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Troikaa Pharmaceuticals Ltd. Main Business Overview
13.4.5 Troikaa Pharmaceuticals Ltd. Latest Developments
13.5 Biological E Limited
13.5.1 Biological E Limited Company Information
13.5.2 Biological E Limited Peptides Product Offered
13.5.3 Biological E Limited Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biological E Limited Main Business Overview
13.5.5 Biological E Limited Latest Developments
13.6 Bharat Biotech
13.6.1 Bharat Biotech Company Information
13.6.2 Bharat Biotech Peptides Product Offered
13.6.3 Bharat Biotech Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bharat Biotech Main Business Overview
13.6.5 Bharat Biotech Latest Developments
13.7 Samarth Life Sciences Pvt. Ltd.
13.7.1 Samarth Life Sciences Pvt. Ltd. Company Information
13.7.2 Samarth Life Sciences Pvt. Ltd. Peptides Product Offered
13.7.3 Samarth Life Sciences Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Samarth Life Sciences Pvt. Ltd. Main Business Overview
13.7.5 Samarth Life Sciences Pvt. Ltd. Latest Developments
13.8 VHB Life Sciences Limited
13.8.1 VHB Life Sciences Limited Company Information
13.8.2 VHB Life Sciences Limited Peptides Product Offered
13.8.3 VHB Life Sciences Limited Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 VHB Life Sciences Limited Main Business Overview
13.8.5 VHB Life Sciences Limited Latest Developments
13.9 Celon Laboratories Pvt. Ltd.
13.9.1 Celon Laboratories Pvt. Ltd. Company Information
13.9.2 Celon Laboratories Pvt. Ltd. Peptides Product Offered
13.9.3 Celon Laboratories Pvt. Ltd. Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Celon Laboratories Pvt. Ltd. Main Business Overview
13.9.5 Celon Laboratories Pvt. Ltd. Latest Developments
13.10 United Biotech(P) Limited
13.10.1 United Biotech(P) Limited Company Information
13.10.2 United Biotech(P) Limited Peptides Product Offered
13.10.3 United Biotech(P) Limited Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 United Biotech(P) Limited Main Business Overview
13.10.5 United Biotech(P) Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Peptides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Peptides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Insulin
Table 4. Major Players of Teriparatide
Table 5. Major Players of Liraglutide
Table 6. Major Players of Leuprolide
Table 7. Global Peptides Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Peptides Sales Market Share by Type (2017-2022)
Table 9. Global Peptides Revenue by Type (2017-2022) & ($ million)
Table 10. Global Peptides Revenue Market Share by Type (2017-2022)
Table 11. Global Peptides Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Peptides Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Peptides Sales Market Share by Application (2017-2022)
Table 14. Global Peptides Revenue by Application (2017-2022)
Table 15. Global Peptides Revenue Market Share by Application (2017-2022)
Table 16. Global Peptides Sale Price by Application (2017-2022) & (USD/Pcs)
Table 17. Global Peptides Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Peptides Sales Market Share by Company (2020-2022)
Table 19. Global Peptides Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Peptides Revenue Market Share by Company (2020-2022)
Table 21. Global Peptides Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Peptides Producing Area Distribution and Sales Area
Table 23. Players Peptides Products Offered
Table 24. Peptides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Peptides Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Peptides Sales Market Share Geographic Region (2017-2022)
Table 29. Global Peptides Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Peptides Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Peptides Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Peptides Sales Market Share by Country/Region (2017-2022)
Table 33. Global Peptides Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Peptides Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Peptides Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Peptides Sales Market Share by Country (2017-2022)
Table 37. Americas Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Peptides Revenue Market Share by Country (2017-2022)
Table 39. Americas Peptides Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Peptides Sales Market Share by Type (2017-2022)
Table 41. Americas Peptides Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Peptides Sales Market Share by Application (2017-2022)
Table 43. APAC Peptides Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Peptides Sales Market Share by Region (2017-2022)
Table 45. APAC Peptides Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Peptides Revenue Market Share by Region (2017-2022)
Table 47. APAC Peptides Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Peptides Sales Market Share by Type (2017-2022)
Table 49. APAC Peptides Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Peptides Sales Market Share by Application (2017-2022)
Table 51. Europe Peptides Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Peptides Sales Market Share by Country (2017-2022)
Table 53. Europe Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Peptides Revenue Market Share by Country (2017-2022)
Table 55. Europe Peptides Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Peptides Sales Market Share by Type (2017-2022)
Table 57. Europe Peptides Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Peptides Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Peptides Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Peptides Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Peptides Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Peptides Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Peptides Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Peptides Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Peptides Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Peptides
Table 68. Key Market Challenges & Risks of Peptides
Table 69. Key Industry Trends of Peptides
Table 70. Peptides Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Peptides Distributors List
Table 73. Peptides Customer List
Table 74. Global Peptides Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Peptides Sales Market Forecast by Region
Table 76. Global Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Peptides Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Peptides Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Peptides Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Peptides Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Peptides Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Peptides Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Peptides Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Peptides Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Peptides Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Peptides Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Peptides Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Peptides Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Peptides Revenue Market Share Forecast by Application (2023-2028)
Table 94. Cipla Ltd. Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 95. Cipla Ltd. Peptides Product Offered
Table 96. Cipla Ltd. Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Cipla Ltd. Main Business
Table 98. Cipla Ltd. Latest Developments
Table 99. Emcure Pharmaceuticals Pvt. Ltd. Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 100. Emcure Pharmaceuticals Pvt. Ltd. Peptides Product Offered
Table 101. Emcure Pharmaceuticals Pvt. Ltd. Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Emcure Pharmaceuticals Pvt. Ltd. Main Business
Table 103. Emcure Pharmaceuticals Pvt. Ltd. Latest Developments
Table 104. Gland Pharma Limited Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 105. Gland Pharma Limited Peptides Product Offered
Table 106. Gland Pharma Limited Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Gland Pharma Limited Main Business
Table 108. Gland Pharma Limited Latest Developments
Table 109. Troikaa Pharmaceuticals Ltd. Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 110. Troikaa Pharmaceuticals Ltd. Peptides Product Offered
Table 111. Troikaa Pharmaceuticals Ltd. Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Troikaa Pharmaceuticals Ltd. Main Business
Table 113. Troikaa Pharmaceuticals Ltd. Latest Developments
Table 114. Biological E Limited Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 115. Biological E Limited Peptides Product Offered
Table 116. Biological E Limited Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Biological E Limited Main Business
Table 118. Biological E Limited Latest Developments
Table 119. Bharat Biotech Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 120. Bharat Biotech Peptides Product Offered
Table 121. Bharat Biotech Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. Bharat Biotech Main Business
Table 123. Bharat Biotech Latest Developments
Table 124. Samarth Life Sciences Pvt. Ltd. Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 125. Samarth Life Sciences Pvt. Ltd. Peptides Product Offered
Table 126. Samarth Life Sciences Pvt. Ltd. Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 127. Samarth Life Sciences Pvt. Ltd. Main Business
Table 128. Samarth Life Sciences Pvt. Ltd. Latest Developments
Table 129. VHB Life Sciences Limited Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 130. VHB Life Sciences Limited Peptides Product Offered
Table 131. VHB Life Sciences Limited Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 132. VHB Life Sciences Limited Main Business
Table 133. VHB Life Sciences Limited Latest Developments
Table 134. Celon Laboratories Pvt. Ltd. Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 135. Celon Laboratories Pvt. Ltd. Peptides Product Offered
Table 136. Celon Laboratories Pvt. Ltd. Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 137. Celon Laboratories Pvt. Ltd. Main Business
Table 138. Celon Laboratories Pvt. Ltd. Latest Developments
Table 139. United Biotech(P) Limited Basic Information, Peptides Manufacturing Base, Sales Area and Its Competitors
Table 140. United Biotech(P) Limited Peptides Product Offered
Table 141. United Biotech(P) Limited Peptides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 142. United Biotech(P) Limited Main Business
Table 143. United Biotech(P) Limited Latest Developments
List of Figures
Figure 1. Picture of Peptides
Figure 2. Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peptides Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Peptides Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Peptides Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Insulin
Figure 10. Product Picture of Teriparatide
Figure 11. Product Picture of Liraglutide
Figure 12. Product Picture of Leuprolide
Figure 13. Global Peptides Sales Market Share by Type in 2021
Figure 14. Global Peptides Revenue Market Share by Type (2017-2022)
Figure 15. Peptides Consumed in Diabetes
Figure 16. Global Peptides Market: Diabetes (2017-2022) & (K Pcs)
Figure 17. Peptides Consumed in Infectious Diseases
Figure 18. Global Peptides Market: Infectious Diseases (2017-2022) & (K Pcs)
Figure 19. Peptides Consumed in Cancer
Figure 20. Global Peptides Market: Cancer (2017-2022) & (K Pcs)
Figure 21. Peptides Consumed in Osteoporosis
Figure 22. Global Peptides Market: Osteoporosis (2017-2022) & (K Pcs)
Figure 23. Global Peptides Sales Market Share by Application (2017-2022)
Figure 24. Global Peptides Revenue Market Share by Application in 2021
Figure 25. Peptides Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Peptides Revenue Market Share by Company in 2021
Figure 27. Global Peptides Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Peptides Revenue Market Share by Geographic Region in 2021
Figure 29. Global Peptides Sales Market Share by Region (2017-2022)
Figure 30. Global Peptides Revenue Market Share by Country/Region in 2021
Figure 31. Americas Peptides Sales 2017-2022 (K Pcs)
Figure 32. Americas Peptides Revenue 2017-2022 ($ Millions)
Figure 33. APAC Peptides Sales 2017-2022 (K Pcs)
Figure 34. APAC Peptides Revenue 2017-2022 ($ Millions)
Figure 35. Europe Peptides Sales 2017-2022 (K Pcs)
Figure 36. Europe Peptides Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Peptides Sales 2017-2022 (K Pcs)
Figure 38. Middle East & Africa Peptides Revenue 2017-2022 ($ Millions)
Figure 39. Americas Peptides Sales Market Share by Country in 2021
Figure 40. Americas Peptides Revenue Market Share by Country in 2021
Figure 41. United States Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Peptides Sales Market Share by Region in 2021
Figure 46. APAC Peptides Revenue Market Share by Regions in 2021
Figure 47. China Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Peptides Sales Market Share by Country in 2021
Figure 54. Europe Peptides Revenue Market Share by Country in 2021
Figure 55. Germany Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Peptides Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Peptides Revenue Market Share by Country in 2021
Figure 62. Egypt Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Peptides in 2021
Figure 68. Manufacturing Process Analysis of Peptides
Figure 69. Industry Chain Structure of Peptides
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...